World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
34153
World Ranking
8042
National Ranking
4174

Beow Y. Yeap publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Beow Y. Yeap sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 363 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Beow Y. Yeap D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Beow Y. Yeap sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Beow Y. Yeap is affiliated with Harvard University in the United States and has a research focus primarily in Medicine, with significant contributions in the subfields of Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics, and Molecular Biology.

The researcher's work spans several main topics including Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research, Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, and Lung Cancer Diagnosis and Treatment.

The recent publications reflect these areas of study and include:

  • Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial, 2021, Nature Cancer
  • MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer, 2020, Clinical Cancer Research
  • Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer, 2021, Clinical Cancer Research
  • Therapy-induced APOBEC3A drives evolution of persistent cancer cells, 2023, Nature
  • Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation, 2020, International Journal of Radiation Oncology*Biology*Physics

Frequent co-authors collaborating with Beow Y. Yeap include Theodore S. Hong, Justin F. Gainor, Jennifer Y. Wo, W. Marston Linehan, and Torunn I. Yock.

The researcher's publications appear mainly in the following venues:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Thoracic Oncology
  • Neuro-Oncology
  • JTO Clinical and Research Reports

Best Publications

  • Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Alice T. Shaw;Beow Y. Yeap;Mari Mino-Kenudson;Subba R. Digumarthy

  • Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

    Alexa B. Turke;Kreshnik Zejnullahu;Yi Long Wu;Youngchul Song

  • Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.

    Alice T. Shaw;Beow Y. Yeap;Benjamin J. Solomon;Gregory J. Riely

  • EGFR Mutations and ALK Rearrangements Are Associated With Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis

    Justin F. Gainor;Alice T. Shaw;Lecia V. Sequist;Xiujun Fu

  • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

    Scott J. Rodig;Mari Mino-Kenudson;Sanja Dacic;Beow Y. Yeap

  • Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

    David M. Jackman;Beow Y. Yeap;Lecia V. Sequist;Neal Lindeman

  • ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer

    Justin F. Gainor;Anna M. Varghese;Sai-Hong Ignatius Ou;Sheheryar Kabraji

  • Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non–Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials

    David M. Jackman;Vincent A. Miller;Leigh-Anne Cioffredi;Beow Y. Yeap

  • Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

    Jeffrey A. Engelman;Toru Mukohara;Kreshnik Zejnullahu;Eugene Lifshits

  • Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial

    Janet E. Murphy;Jennifer Y. Wo;David P. Ryan;Wenqing Jiang

  • Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

    Theodore S. Hong;Jennifer Y. Wo;Beow Y. Yeap;Edgar Ben-Josef

  • The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal Tumors

    Jean Pierre E N Pierie;Umar H Choudry;Alona Muzikansky;Beow Yong Yeap

  • Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

    David M. Jackman;Beow Y. Yeap;Neal I. Lindeman;Panos Fidias

  • Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.

    Janet E. Murphy;Jennifer Y. Wo;David P. Ryan;Jeffrey W. Clark

  • Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

    Toru Mukohara;Jeffrey A. Engelman;Nasser H. Hanna;Beow Y. Yeap

  • Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.

    Stephanie Cardarella;Atsuko Ogino;Mizuki Nishino;Mohit Butaney

  • Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

    George N. Naumov;Monique B. Nilsson;Tina Cascone;Alexandra Briggs

  • Double unrelated reduced-intensity umbilical cord blood transplantation in adults

    Karen K. Ballen;Thomas R. Spitzer;Beow Y. Yeap;Steven McAfee

  • Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition

    Anthony C. Faber;Danan Li;Young Chul Song;Mei-Chih Liang

  • Diabetes Impairs Hematopoietic Stem Cell Mobilization by Altering Niche Function

    Francesca Ferraro;Stefania Lymperi;Simón Méndez-Ferrer;Borja Saez

Frequent Co-Authors

Thomas F. DeLaney
Thomas F. DeLaney Harvard University
Alice T. Shaw
Alice T. Shaw Harvard University
David P. Ryan
David P. Ryan Harvard University
Nancy J. Tarbell
Nancy J. Tarbell Harvard University
Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Andrew X. Zhu
Andrew X. Zhu Harvard University
David J. Sugarbaker
David J. Sugarbaker Baylor College of Medicine
William G. Richards
William G. Richards Brigham and Women's Hospital
Justin F. Gainor
Justin F. Gainor Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing Medicine in the USA is a common route, there are numerous alternative healthcare careers and online degree options to consider. For those interested in direct patient care without a prior nursing background, online bsn programs for non nurses offer an accessible way to fast-track a Bachelor of Science in Nursing and start working in the field quickly.

If you prefer the business or administrative side of healthcare, exploring a accelerated healthcare administration degree program online could open doors to management and leadership roles within hospitals or clinics. Similarly, those looking for quick entry into the workforce can find promising prospects at the best online medical billing and coding schools, which train you for in-demand administrative positions.

For individuals drawn to practical nursing roles, attending an lpn school without teas test can streamline the admissions process and help you start your Licensed Practical Nurse (LPN) journey sooner. Each of these pathways enables you to contribute meaningfully to healthcare, often with more flexibility and faster completion times than traditional medical degrees.

Best Scientists Citing Beow Y. Yeap

Trending Scientists

Recently Published Articles